LUX-HEAD&NECK 1: A PHASE III TRIAL OF AFATINIB (BIBW2992) VERSUS METHOTREXATE FOR THE TREATMENT OF RECURRENT AND/OR METASTATIC (R/M) HEAD AND NECK SQUAMOUS CELL CANCER AFTER PLATINUM BASED CHEMOTHERAPY: